Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.30 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22944725 | 0.91 | MAPT (0.35) | MAPTKDM4EALDH1A1HPGDRAB9A | |
| SCHEMBL22946021 | 0.89 | MAPT (0.32) | MAPTKDM4EALDH1A1HPGDRAB9A | |
| SCHEMBL22945010 | 0.89 | MAPT (0.33) | MAPTKDM4EALDH1A1HPGDRAB9A | |
| SCHEMBL22944810 | 0.88 | PDE6D (0.31) | — | |
| SCHEMBL22944815 | 0.88 | MAPT (0.34) | MAPTKDM4EALDH1A1HPGDRAB9A | |
| SCHEMBL22945155 | 0.84 | HPGD (0.39) | MAPTKDM4EALDH1A1HPGDRAB9A | |
| SCHEMBL22944857 | 0.81 | PRKCI (0.30) | — | |
| SCHEMBL26737064 | 0.81 | PDE6D (0.33) | MAPTKDM4EALDH1A1 | |
| SCHEMBL26737063 | 0.81 | KDM4E (0.30) | MAPTKDM4EALDH1A1 | |
| SCHEMBL22945446 | 0.80 | KDM4E (0.34) | KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11812658-B2 | Compound and organic light emitting diode comprising same | LG CHEM, LTD. (KR) | 2023-11-07 | — | — | US | disclosed |
| US-11812658-B2 | Compound and organic light emitting diode comprising same | LG CHEM, LTD. (KR) | 2023-11-07 | — | — | US | disclosed |
| US-20210036236-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | LG CHEM, LTD. (KR) | 2021-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210036236-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | DRD1, DRD3, DRD2 | MAPT 2771/4885KDM4E 1857/4885ALDH1A1 271/4885 |
| US-11812658-B2 | Compound and organic light emitting diode comprising same | DRD1, DRD3, DRD2 | MAPT 2771/4885KDM4E 1857/4885ALDH1A1 271/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.